BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21895576)

  • 1. CTCF function is modulated by neighboring DNA binding factors.
    Weth O; Renkawitz R
    Biochem Cell Biol; 2011 Oct; 89(5):459-68. PubMed ID: 21895576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTCF maintains differential methylation at the Igf2/H19 locus.
    Schoenherr CJ; Levorse JM; Tilghman SM
    Nat Genet; 2003 Jan; 33(1):66-9. PubMed ID: 12461525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of Igf2/H19 imprinting at CTCF insulator binding sites.
    Yang Y; Hu JF; Ulaner GA; Li T; Yao X; Vu TH; Hoffman AR
    J Cell Biochem; 2003 Dec; 90(5):1038-55. PubMed ID: 14624463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene.
    Bell AC; Felsenfeld G
    Nature; 2000 May; 405(6785):482-5. PubMed ID: 10839546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
    Hark AT; Schoenherr CJ; Katz DJ; Ingram RS; Levorse JM; Tilghman SM
    Nature; 2000 May; 405(6785):486-9. PubMed ID: 10839547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTCF binding sites promote transcription initiation and prevent DNA methylation on the maternal allele at the imprinted H19/Igf2 locus.
    Engel N; Thorvaldsen JL; Bartolomei MS
    Hum Mol Genet; 2006 Oct; 15(19):2945-54. PubMed ID: 16928784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer-blocking activity is associated with hypersensitive site V sequences in the human growth hormone locus control region.
    Jin Y; Oomah K; Cattini PA
    DNA Cell Biol; 2011 Dec; 30(12):995-1005. PubMed ID: 21711161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CTCF binding sites in the Igf2/H19 imprinting control region.
    Szabó PE; Tang SH; Silva FJ; Tsark WM; Mann JR
    Mol Cell Biol; 2004 Jun; 24(11):4791-800. PubMed ID: 15143173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTCF binding and higher order chromatin structure of the H19 locus are maintained in mitotic chromatin.
    Burke LJ; Zhang R; Bartkuhn M; Tiwari VK; Tavoosidana G; Kurukuti S; Weth C; Leers J; Galjart N; Ohlsson R; Renkawitz R
    EMBO J; 2005 Sep; 24(18):3291-300. PubMed ID: 16107875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTCF binding is not the epigenetic mark that establishes post-fertilization methylation imprinting in the transgenic H19 ICR.
    Matsuzaki H; Okamura E; Fukamizu A; Tanimoto K
    Hum Mol Genet; 2010 Apr; 19(7):1190-8. PubMed ID: 20047949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
    Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
    Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of a single CTCF target site within the H19 imprinting control region leads to loss of Igf2 imprinting and complex patterns of de novo methylation upon maternal inheritance.
    Pant V; Kurukuti S; Pugacheva E; Shamsuddin S; Mariano P; Renkawitz R; Klenova E; Lobanenkov V; Ohlsson R
    Mol Cell Biol; 2004 Apr; 24(8):3497-504. PubMed ID: 15060168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in the CTCF-binding site I and the expression pattern of the H19 gene: does positive expression predict poor prognosis in early stage head and neck carcinomas?
    Esteves LI; Javaroni AC; Nishimoto IN; Magrin J; Squire JA; Kowalski LP; Rainho CA; Rogatto SR
    Mol Carcinog; 2005 Oct; 44(2):102-10. PubMed ID: 16015666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor.
    Lutz M; Baniahmad A; Renkawitz R
    Biochem Soc Trans; 2000; 28(4):386-9. PubMed ID: 10961925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to Igf2.
    Kurukuti S; Tiwari VK; Tavoosidana G; Pugacheva E; Murrell A; Zhao Z; Lobanenkov V; Reik W; Ohlsson R
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10684-9. PubMed ID: 16815976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTCF-dependent chromatin insulator is linked to epigenetic remodeling.
    Ishihara K; Oshimura M; Nakao M
    Mol Cell; 2006 Sep; 23(5):733-42. PubMed ID: 16949368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete biallelic insulation at the H19/Igf2 imprinting control region position results in fetal growth retardation and perinatal lethality.
    Lee DH; Singh P; Tsark WM; Szabó PE
    PLoS One; 2010 Sep; 5(9):e12630. PubMed ID: 20838620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations.
    Engel N; West AG; Felsenfeld G; Bartolomei MS
    Nat Genet; 2004 Aug; 36(8):883-8. PubMed ID: 15273688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of imprinting of insulin-like growth factor-II in Wilms' tumor commonly involves altered methylation but not mutations of CTCF or its binding site.
    Cui H; Niemitz EL; Ravenel JD; Onyango P; Brandenburg SA; Lobanenkov VV; Feinberg AP
    Cancer Res; 2001 Jul; 61(13):4947-50. PubMed ID: 11431321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders.
    Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C
    Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.